Covered recipient · General Payments record
SMITHA GUDIPATI
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2019–2024
$10,989.42
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $5,940.00 | 2 |
| Travel and Lodging | $552.23 | 2 |
| Food and Beverage | $473.81 | 5 |
| Education | $115.24 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ViiV Healthcare Company | $4,550.00 | 1 |
| Gilead Sciences, Inc. | $2,373.06 | 7 |
| Astellas Pharma US Inc | $99.00 | 1 |
| Merck Sharp & Dohme Corporation | $42.98 | 1 |
| Insmed, Inc. | $16.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $99.00 | 03/11/2024 | Education | Undisputed | 01/23/2026 | 1139344772 | CMS |
| Gilead Sciences, Inc. | $101.82 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133819735 | CMS |
| Gilead Sciences, Inc. | $93.75 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133819737 | CMS |
| Gilead Sciences, Inc. | $85.42 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133819739 | CMS |
| Gilead Sciences, Inc. | $149.84 | 10/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133819741 | CMS |
| Gilead Sciences, Inc. | $264.30 | 10/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133868388 | CMS |
| Gilead Sciences, Inc. | $287.93 | 10/19/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1133868390 | CMS |
| Gilead Sciences, Inc. | $1,390.00 | 11/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133599805 | CMS |
| Insmed, Inc. | $16.24 | 10/25/2024 | Education | Undisputed | 01/23/2026 | 1089560066 | CMS |
| Merck Sharp & Dohme LLC | $42.98 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141775365 | CMS |
| ViiV Healthcare Company | $4,550.00 | 01/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1112813949 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.